Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Moore

Showing results (111-120 of 225) with videos related to

Pageof 23
Sort By:
Archives of Internal Medicine|October 1, 1992
Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology GroupR E Chaisson, J Keruly, D D Richman, et al.
Surgical Technology International|July 7, 2009
Minimally invasive treatment for female stress urinary incontinence (SUI): a review including TVT, TOT, and mini-slingR D Moore, S R Serels, G W Davila, et al.
Journal of Acquired Immune Deficiency Syndromes|April 1, 1994
Zidovudine therapy and health resource utilization in AIDSR D Moore, J Hidalgo, J C Bareta, et al.
The British Journal of Radiology|July 1, 1993
Routine quality assurance of high frequency ultrasound breast scanners in a screening contextJ A Evans, R D Moore, S C Metcalfe, et al.
Journal of Medical Education|February 1, 1983
Effectiveness of medical consultationL E Klein, R D Moore, D M Levine, et al.
The New England Journal of Medicine|May 16, 1991
Zidovudine and the natural history of the acquired immunodeficiency syndromeR D Moore, J Hidalgo, B W Sugland, et al.
AIDS (London, England)|February 10, 1998
Impact of opportunistic disease on survival in patients with HIV infectionR E Chaisson, J E Gallant, J C Keruly, et al.
The American Journal of Physiology|January 1, 1982
Intracellular pH mediates action of insulin on glycolysis in frog skeletal muscleM L Fidelman, S H Seeholzer, K B Walsh, et al.
AIDS (London, England)|April 15, 1999
Stavudine in zidovudine (ZDV)-experienced compared with ZDV-naive patientsJ E Gallant, R E Chaisson, J C Keruly, et al.
The Journal of Infectious Diseases|April 1, 1996
Risk factors for pneumococcal disease in human immunodeficiency virus-infected patientsK A Gebo, R D Moore, J C Keruly, et al.
Pageof 23

Showing results (111-120 of 225) with videos related to

Sort By:
Pageof 23
Archives of Internal Medicine|October 1, 1992
Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology GroupR E Chaisson, J Keruly, D D Richman, et al.
Surgical Technology International|July 7, 2009
Minimally invasive treatment for female stress urinary incontinence (SUI): a review including TVT, TOT, and mini-slingR D Moore, S R Serels, G W Davila, et al.
Journal of Acquired Immune Deficiency Syndromes|April 1, 1994
Zidovudine therapy and health resource utilization in AIDSR D Moore, J Hidalgo, J C Bareta, et al.
The British Journal of Radiology|July 1, 1993
Routine quality assurance of high frequency ultrasound breast scanners in a screening contextJ A Evans, R D Moore, S C Metcalfe, et al.
Journal of Medical Education|February 1, 1983
Effectiveness of medical consultationL E Klein, R D Moore, D M Levine, et al.
The New England Journal of Medicine|May 16, 1991
Zidovudine and the natural history of the acquired immunodeficiency syndromeR D Moore, J Hidalgo, B W Sugland, et al.
AIDS (London, England)|February 10, 1998
Impact of opportunistic disease on survival in patients with HIV infectionR E Chaisson, J E Gallant, J C Keruly, et al.
The American Journal of Physiology|January 1, 1982
Intracellular pH mediates action of insulin on glycolysis in frog skeletal muscleM L Fidelman, S H Seeholzer, K B Walsh, et al.
AIDS (London, England)|April 15, 1999
Stavudine in zidovudine (ZDV)-experienced compared with ZDV-naive patientsJ E Gallant, R E Chaisson, J C Keruly, et al.
The Journal of Infectious Diseases|April 1, 1996
Risk factors for pneumococcal disease in human immunodeficiency virus-infected patientsK A Gebo, R D Moore, J C Keruly, et al.
Pageof 23